๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Stage IV Ovarian Cancer

CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors NCT05733000Phase 21 site๐Ÿ“ Chicago Northwestern University ยท Tests: Biospecimen Collection, Computed Tomography, Devimistat, Fluorouracil, Gemcitabine Hydrochloride Microdevice In Ovarian, Fallopian Tube, And Peritoneal Cancer NCT04701645Phase 12 sites๐Ÿ“ Boston๐Ÿ“ Boston Brigham and Women's Hospital ยท Tests: Microdevice Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors NCT03067181Phase 3629 sites๐Ÿ“ Birmingham๐Ÿ“ Mobile๐Ÿ“ Anchorage Children's Oncology Group ยท Tests: Best Practice, Biopsy Procedure, Biospecimen Collection, Bleomycin Sulfate, Carboplatin Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer NCT06580314Phase 3695 sites๐Ÿ“ Birmingham๐Ÿ“ Anchorage๐Ÿ“ Anchorage NRG Oncology ยท Tests: Bevacizumab, Biospecimen Collection, Computed Tomography, Magnetic Resonance Imaging, Olaparib CLDN6/GPC3/Mesothelin/AXL-CAR-NK Cell Therapy for Advanced Solid Tumors NCT05410717Phase 11 site๐Ÿ“ Guangzhou Second Affiliated Hospital of Guangzhou Medical University ยท Tests: Claudin6, GPC3, Mesothelin, or AXL targeting CAR-NK cells Trastzumab Deruxtecan Versus SOC in Recurrent Ovarian That Progressed on Prior PARP Inhibitor Therapy NCT07340164Phase 21 site๐Ÿ“ Seoul Yonsei University ยท Tests: Trastzumab Deruxtecan, Bevacizumab, Platinum Based Chemotherapy Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer NCT05659381Phase 359 sites๐Ÿ“ Duarte๐Ÿ“ La Jolla๐Ÿ“ Newport Beach GOG Foundation ยท Tests: Cisplatin, No treatment IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors NCT05039801Phase 11 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Bevacizumab, Glutaminase-1 Inhibitor IACS-6274, Paclitaxel, Capivasertib Anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers NCT05296564Phase 1, Phase 21 site๐Ÿ“ Jerusalem Hadassah Medical Organization ยท Tests: CYCLOPHOSPHAMIDE and FLUDARABIN, Cyclophosphamide, HBI 0201-ESO TCRT, Aldesleukin A Phase I/II, First-in-Human Study to Evaluate TJ102 in Participants With Advanced or Metastatic Ovarian Cancer and Other Solid Tumors. NCT07778498Phase 1, Phase 29 sites๐Ÿ“ Los Angeles๐Ÿ“ Orlando๐Ÿ“ Lake Success Phrontline Biopharma ยท Tests: TJ102 Sequential CD146 and GPC3 CAR-T Cell Therapy in Advanced Ovarian Cancer NCT07067255Phase 1, Phase 21 site๐Ÿ“ Beijing Essen Biotech ยท Tests: GPC3 CD146 CAR-T cells A Study to Evaluate the Safety,Pharmacokinetics,Pharmacodynamics,and Efficacy of TJ037130 in Adult Participants With Advanced Solid Tumors NCT07715747Phase 11 site๐Ÿ“ Shanghai TJ Biopharma Co., Ltd. ยท Tests: TJ037130 Genetic Landscape in Women with Metastatic Ovarian Cancer Before and During Treatment with PARP Inhibitors NCT06785077NA1 site๐Ÿ“ Milan European Institute of Oncology ยท Tests: buccal cells, bone marrow cells, peripheral blood cells, bone marrow biopsy CATALINA-4: A Study to Investigate the Safety and Efficacy of TORL-1-23 With Chemotherapy Given Before Initial Surgery in Women With Advanced Stage Ovarian Cancer NCT07322094Phase 1, Phase 27 sites๐Ÿ“ Fullerton๐Ÿ“ Irvine๐Ÿ“ Los Angeles TORL Biotherapeutics, LLC ยท Tests: TORL-1-23 and paclitaxel, TORL-1-23 and carboplatin, TORL-1-23, paclitaxel, and carboplatin Measuring Oncological Value of Exercise and Statin NCT05796973Phase 31 site๐Ÿ“ Tampere Tampere University Hospital ยท Tests: Guided physical exercise, Atorvastatin, Independent exercise The Sarah Nanotechnology System for Treatment of Advanced Metastatic Solid Tumors Using Hyperthermia. NCT07224464NA1 site๐Ÿ“ Rochester New Phase Ltd. ยท Tests: The Sarah Nanotechnology System - intended to deliver thermal energy to malignant cells for the purpose of thermal destโ€ฆ Adjuvant Chemotherapy of Three-step Regimen in BRCA1/2 Wide Type Ovarian Cancer (ACTS-2) NCT04520074Phase 31 site๐Ÿ“ Shanghai Fudan University ยท Tests: Etoposide, Cyclophosphamide, Carboplatin/Cisplatin A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRฮฑ)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer. NCT06890338Phase 273 sites๐Ÿ“ Birmingham๐Ÿ“ Mobile๐Ÿ“ Irvine AbbVie ยท Tests: Carboplatin, Mirvetuximab Soravtansine, Bevacizumab A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of INV-6452 in Adult Patients With Hormone Receptor Positive, Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Advanced/Metastatic Breast Cancer or Locally Advanced/Metastatic Solid Tumor NCT07612891Phase 1, Phase 21 site๐Ÿ“ Shanghai Shenzhen Ionova Life Sciences Co., Ltd. ยท Tests: INV-6452 Phase 1 Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of ARR-002 in Advanced or Metastatic Ovarian or Endometrial Cancer. NCT07755436Phase 16 sites๐Ÿ“ Orlando๐Ÿ“ Boston๐Ÿ“ Nashville ArriVent BioPharma, Inc. ยท Tests: ARR-002 Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer NCT01174121Phase 21 site๐Ÿ“ Bethesda National Cancer Institute (NCI) ยท Tests: Pembrolizumab (Keytruda), Fludarabine, Cyclophosphamide, Aldesleukin, Young TIL Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors NCT07444814Phase 112 sites๐Ÿ“ Little Rock๐Ÿ“ Los Angeles๐Ÿ“ Peoria Whitehawk Therapeutics, Inc. ยท Tests: HWK-007 Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers NCT03968406Phase 12 sites๐Ÿ“ Baltimore๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Quality-of-Life Assessment, Radiation Therapy, Talazoparib Exercise as a Preventive Agent to Combat Immobility in Patients With Ovarian or Endometrial Cancers Receiving Chemotherapy NCT04997096NA1 site๐Ÿ“ Boston Dana-Farber Cancer Institute ยท Tests: Exercise, Attention Control Tinzaparin And Biomarkers After Neoadjuvant Treatment of Ovarian Cancer NCT05284552Phase 28 sites๐Ÿ“ Eksjรถ๐Ÿ“ Gothenburg๐Ÿ“ Jรถnkรถping University Hospital, Linkoeping ยท Tests: Tinzaparin Injectable Solution A Study to Assess Adverse Events and Change in Disease Activity in Participants With Platinum-Resistant Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression Treated With Intravenously (IV) Infused Mirvetuximab Soravtansine NCT06682988Phase 252 sites๐Ÿ“ Sarasota๐Ÿ“ Edgewood๐Ÿ“ Lexington AbbVie ยท Tests: Mirvetuximab Soravtansine The EASE Study: Randomized Trial of a Novel Approach to Addressing Fear of Progression in Advanced Cancer NCT07636200NA2 sites๐Ÿ“ Aurora๐Ÿ“ Boulder University of Colorado, Boulder ยท Tests: Written Exposure-Based Coping Intervention (EASE), Usual Care Control Condition Newly Diagnosed Stage III/IV Ovarian Cancer, Neoadjuvant Carbo/Taxol/Pembro, Maintenance Olaparib/Pembro NCT05952453Phase 21 site๐Ÿ“ Birmingham University of Alabama at Birmingham ยท Tests: Carboplatin, olaparibp, embro PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer NCT04329494Phase 13 sites๐Ÿ“ Duarte๐Ÿ“ Jacksonville๐Ÿ“ Greenlawn City of Hope Medical Center ยท Tests: Biopsy, Cisplatin, Doxorubicin, Fluorouracil, Intraperitoneal Chemotherapy PARP (Poly (ADP-ribose) Polymerase) Inhibitor With or Without Angiogenesis Inhibitor in Homologous Recombination Deficient Primary Ovarian Cancer, Fallopian-Tube Cancer, or Primary Peritoneal Cancer NCT07472140Phase 2, Phase 31 site๐Ÿ“ Minsk N.N. Alexandrov National Cancer Centre ยท Tests: PARP inhibitor + Bevacizumab, PARP inhibitor
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy